Lippincott Journals Subscribers, use your username or email along with your password to log in.
Registered users can save articles, searches, and manage email alerts.
All registration fields are required.
Friend's E-mail is Invalid
Your message has been successfully sent to your friend.
Dr. Larry Mellick says racemic epinephrine’s
benefits in patients with croup, asthma, and bronchiolitis have been
overshadowed by unfounded rumors of its adverse effects. (http://bit.ly/EMN-Mellick.)